Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

CD137 Antikörper

Der Ziege Polyklonal anti-CD137 Antikörper (ABIN116397) detektiert spezifisch CD137 in WB und EIA. Dieser Antikörper reagiert spezifisch mit Proben aus Human.
Produktnummer ABIN116397
501,54 €
Zzgl. Versandkosten 20,00 € und MwSt
50 μg
Lieferung nach: Deutschland
Lieferung in 16 Werktagen

Kurzübersicht für CD137 Antikörper (ABIN116397)

Target

Alle CD137 (TNFRSF9) Antikörper anzeigen
CD137 (TNFRSF9) (Tumor Necrosis Factor Receptor Superfamily, Member 9 (TNFRSF9))

Reaktivität

  • 153
  • 88
  • 38
  • 8
  • 4
  • 2
  • 1
Human

Wirt

  • 72
  • 68
  • 44
  • 17
  • 11
  • 4
Ziege

Klonalität

  • 143
  • 67
  • 4
Polyklonal

Konjugat

  • 112
  • 18
  • 14
  • 10
  • 8
  • 4
  • 4
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser CD137 Antikörper ist unkonjugiert

Applikation

  • 100
  • 84
  • 81
  • 36
  • 33
  • 21
  • 14
  • 11
  • 10
  • 7
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
Western Blotting (WB), Enzyme Immunoassay (EIA)
  • Spezifität

    This antibody reacts with 4-1BB Receptor.

    Aufreinigung

    Affinity Chromatography employing immobilized h4-1BB Receptor.

    Immunogen

    Highly pure (>98%) recombinant Human 4-1BB Receptor.
  • Applikationshinweise

    Neutrlization. ELISAIndirect: To detect Human 4-1BB Receptor by indirect ELISA (using 100 μL/well antibodysolution) a concentration of 0.5-2.0 μg/mL of this antibody is required. This antigen affinitypurified antibody, in conjunction with compatible secondary reagents, allows the detectionof at least 0.2-0.4 ng/well of recombinant Human 4-1BB Receptor. Sandwich: To detect Human 4-1BB Receptor by sandwich ELISA (using 100 μL/well antibodysolution) a concentration of 0.5-2.0 μg/mL of this antibody is required. This antigen affinitypurified antibody, in conjunction with with Biotinylated Anti-Human 4-1BB Receptor(PP1201B1 or PP1201B2) as a detection antibody, allows the detection of at least 0.2-0.4 ng/well of recombinant Human 4-1BB Receptor. Western BlotTo detect Human 4-1BB Receptor, this antibody can be used at a concentration of 0.1-0.2 μg/mL. Used in conjunction with compatible secondary reagents the detection limit forrecombinant Human 4-1BB Receptor is 1.5-3.0 ng/lane, under either reducing ornon-reducing conditions.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Rekonstitution

    Restore in sterile water to a concentration of 0.1-1.0 mg/mL.

    Buffer

    PBS, pH 7.2 without preservatives.

    Konservierungsmittel

    Without preservative

    Handhabung

    Avoid repeated freezing and thawing.

    Lagerung

    4 °C/-20 °C

    Informationen zur Lagerung

    Store the antibody prior to reconstitution at -20 °C. Following reconstitution the antibody can be stored at 2-8 °C for one month or at -20 °C for longer.
  • Target

    CD137 (TNFRSF9) (Tumor Necrosis Factor Receptor Superfamily, Member 9 (TNFRSF9))

    Andere Bezeichnung

    CD137 / TNFRSF9

    Hintergrund

    4-1BB Receptor (also known as TNFRSF9, CD137 antigen, T-cell antigen ILA), a member of the TNF superfamily of receptors, is mainly expressed on the surface of a variety of T cells, but also found in B cells, monocytes, and various transformed cell lines. 4-1BB Receptor binds to 4-1BBL to provide a co-stimulatory signal for T lymphocytes. Signaling by 4-1BB Receptor has been implicated in the antigen-presentation process and generation of cytotoxic T cells. The human 4-1BB Receptor gene codes for a 255 amino acid type I transmembrane protein containing a 17 amino acid N-terminal signal sequence, a 169 amino acid extracellular domain, a 27 amino acid transmembrane domain and a 42 amino acid cytoplasmic domain.Synonyms: 4-1BB homolog, 4-1BB ligand receptor, CDw137, ILA, T-cell antigen 4-1BB homolog, T-cell antigen ILA, Tumor necrosis factor receptor superfamily member 9

    Gen-ID

    3604

    NCBI Accession

    NP_001552

    UniProt

    Q07011

    Pathways

    Cancer Immune Checkpoints
Sie sind hier:
Chat with us!